Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant.
Nasilowska-Adamska B, Rzepecki P, Manko J, Czyz A, Markiewicz M, Federowicz I, Tomaszewska A, Piatkowska-Jakubas B, Wrzesien-Kus A, Bieniaszewska M, Duda D, Szydlo R, Halaburda K, Szczepinski A, Lange A, Hellman A, Robak T, Skotnicki A, Jedrzejczak WW, Walewski J, Holowiecki J, Komarnicki M, Dmoszynska A, Warzocha K, Marianska B. Nasilowska-Adamska B, et al. Among authors: hellman a. Bone Marrow Transplant. 2007 Nov;40(10):983-8. doi: 10.1038/sj.bmt.1705846. Epub 2007 Sep 10. Bone Marrow Transplant. 2007. PMID: 17846600
Palifermin does not influence the incidence and severity of GvHD nor long-term survival of patients with hematological diseases undergoing HSCT.
Nasilowska-Adamska B, Szydlo R, Rzepecki P, Czyz A, Tomaszewska A, Markiewicz M, Torosian T, Bieniaszewska M, Hellman A, Jedrzejczak WW, Holowiecki J, Komarnicki M, Warzocha K, Marianska B. Nasilowska-Adamska B, et al. Among authors: hellman a. Ann Transplant. 2011 Oct-Dec;16(4):47-54. doi: 10.12659/aot.882218. Ann Transplant. 2011. PMID: 22210421 Clinical Trial.
Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG).
Pluta A, Robak T, Brzozowski K, Stepka K, Wawrzyniak E, Krawczynska A, Czemerska M, Szmigielska-Kaplon A, Grzybowska-Izydorczyk O, Nowicki M, Stelmach P, Kuydowicz M, Gromek T, Hus M, Helbig G, Grosicki S, Bodzenta E, Razny M, Wojcik K, Bolkun L, Kloczko J, Knopinska-Posluszny W, Piekarska A, Hellman A, Sobas M, Wrobel T, Patkowska E, Lech-Maranda E, Warzocha K, Holowiecki J, Giebel S, Wierzbowska A. Pluta A, et al. Among authors: hellman a. Leuk Lymphoma. 2020 Mar;61(3):588-603. doi: 10.1080/10428194.2019.1678151. Epub 2019 Oct 29. Leuk Lymphoma. 2020. PMID: 31661339 Clinical Trial.
[Treatment of acute leukemias in adults. IV. Treatment results on 375 patients at 9 hematology centers].
Apel D, Bielawiec M, Bodzenta A, Brandowska M, Dabrowski S, Gepner-Woźniewska M, Gamski M, Hellman A, Hołowiecki J, Japa J, Jarczak D, Janowska-Wieczorek A, Kiersnowska-Rogowska B, Kłoczko J, Kotlarek-Haus S, Kowalewski J, Krykowski E, Lukjan H, Maj S, Matera M, Mazurowa A, Myśliwiec M, Pawelski S, Robak T, Sowińska J, Urasiński I, Wysocki K. Apel D, et al. Among authors: hellman a. Acta Haematol Pol. 1981 Jul-Dec;12(3-4):155-9. Acta Haematol Pol. 1981. PMID: 7342655 Polish.
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients.
Österborg A, Wierda WG, Mayer J, Hess G, Hillmen P, Schetelig J, Schuh A, Smolej L, Beck C, Dreyfus B, Hellman A, Kozlowski P, Pfreundschuh M, Rizzi R, Spacek M, Phillips JL, Gupta IV, Williams V, Jewell RC, Nebot N, Lisby S, Dyer MJ. Österborg A, et al. Among authors: hellman a. Br J Haematol. 2015 Jul;170(1):40-9. doi: 10.1111/bjh.13380. Epub 2015 Mar 30. Br J Haematol. 2015. PMID: 25825041 Free article. Clinical Trial.
197 results